Cite

HARVARD Citation

    Li, Y. et al. (2017). A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization. Journal of cellular and molecular medicine. 21 (8), pp. 1555-1571. [Online]. 
  
Back to record